War of the agaroses? Purolite says 100,000L plant will cut cost of Protein A
Purolite hopes to reduce the price biopharmaceutical companies have to pay for Protein A with a new 100,000L manufacturing facility.
Purolite hopes to reduce the price biopharmaceutical companies have to pay for Protein A with a new 100,000L manufacturing facility.
Samsung Bioepis has denied it is about to do a biosimilars deal with Eli Lilly after the US drug firm visited its headquarters in Korea.
GSK says the collaboration will attempt to overcome scale-up issues, a major concern among cell and gene therapy developers.